Denali Therapeutics Inc DNLI
NAS: DNLI | ISIN: US24823R1059 30/04/2025
16,65 USD (+0,91%)
(+0,91%)
30/04/2025
Profiel Denali Therapeutics Inc
Website: www.denalitherapeutics.com
Hoofdzetel: South San Francisco, California Verenigde Staten
CEO: Ryan Watts
Werknemers: 433